Biohaven BHVN Income Statement (2021-2026)

NYSE BHVN
$15.59 -0.27 (-1.70%)
As of: Sep 4, 2026 · 11:51 AM EDT
Reported Financials

Biohaven Quarterly Income Statement

Periods 20 quarters
Latest Jun 2026

Biohaven reported net income of -$140.24M for the quarter ended Jun 2026. This income statement covers 20 quarters of results from Sep 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating items
Research & DevelopmentR&D 46.97M41.82M70.10M177.09M52.84M4.25M63.46M79.49M95.52M134.81M155.97M314.82M157.61M167.47M187.58M184.37M141.17M12.00M103.83M100.81M
Selling, General & AdministrativeSG&A 8.52M9.06M19.68M20.02M14.79M76.37M14.32M14.52M15.03M18.90M27.27M18.95M20.56M22.46M33.98M27.33M28.21M20.79M26.60M24.09M
Other Operating ExpensesOther Opex 132.80M109.94M
Operating ExpensesOpex 55.49M50.88M89.77M197.11M67.64M213.41M77.78M94.01M110.55M153.71M183.24M333.77M178.17M189.93M221.56M211.70M169.38M142.73M130.43M124.90M
Operating IncomeOp. Inc -55.49M-50.88M-89.77M-197.11M-67.64M-213.41M-77.78M-94.01M-110.55M-153.71M-183.24M-333.77M-178.17M-189.93M-221.56M-211.70M-169.38M-142.73M-130.43M-124.90M
EBIT -55.49M-50.88M-89.77M-197.11M-67.64M-213.41M-77.78M-94.01M-110.55M-153.71M-183.24M-333.77M-178.17M-189.93M-221.56M-211.70M-169.38M-142.73M-130.43M-124.90M
Non-operating items
Other Non Operating IncomeOther Non Op Inc. -0.01M1.45M-0.00M-0.07M-1.84M8.23M5.84M4.69M7.74M4.30M
Non Operating IncomeNon Op. Inc. -0.01M1.45M-0.00M-0.07M-1.84M8.23M5.84M4.69M7.74M4.30M14.18M17.80M3.14M0.49M13.81M-3.84M-2.47M0.17M-12.02M
Net income details
EBT -55.50M-49.43M-89.78M-197.18M-67.64M-215.25M-69.55M-88.17M-105.86M-145.97M-178.94M-319.59M-160.36M-186.79M-221.07M-197.89M-173.22M-145.20M-130.26M-136.92M
Tax ProvisionsTaxes -1.13M2.46M7.25M6.11M1.22M-14.14M0.94M2.18M-3.29M-1.21M0.57M0.18M-0.06M0.05M0.61M0.26M0.22M0.35M0.27M0.39M
Profit After TaxPAT -54.37M-51.89M-97.03M-203.29M-68.85M-201.11M-70.61M-90.49M-102.57M-144.63M-179.54M-319.77M-160.30M-186.84M-221.68M-198.22M-173.44M-145.51M-130.58M-140.24M
Income from Continuing OperationsIncome (Continuing) -54.37M-51.89M-97.03M-203.29M-68.85M-201.11M-70.49M-90.35M-102.57M-144.76M-179.50M-319.77M-160.30M-186.84M-221.68M-198.15M-173.44M-145.56M-130.53M-137.31M
Consolidated Net IncomeConsol Net Inc. -54.37M-51.89M-97.03M-203.29M-68.85M-201.11M-70.49M-90.35M-102.57M-144.76M-179.50M-319.77M-160.30M-186.84M-221.68M-198.15M-173.44M-145.56M-130.53M-137.31M
Income towards Parent CompanyParent Net Inc -54.37M-51.89M-97.03M-203.29M-68.85M-201.11M-70.49M-90.35M-102.57M-144.76M-179.50M-319.77M-160.30M-186.84M-221.68M-198.15M-173.44M-145.56M-130.53M-137.31M
Net Income towards Common StockholdersNet Income -54.37M-51.89M-97.03M-203.29M-68.85M-201.11M-70.49M-90.35M-102.57M-144.76M-179.50M-319.77M-160.30M-186.84M-221.68M-198.15M-173.44M-145.56M-130.53M-137.31M
Additional items
EPS (Basic) -1.38-1.32-2.46-5.16-1.75-4.49-1.03-1.32-1.50-2.03-2.20-3.64-1.70-2.05-2.17-1.94-1.64-1.35-0.88-0.91
EPS (Diluted) -1.38-1.32-2.46-5.16-1.75-4.49-1.03-1.32-1.50-2.03-2.20-3.64-1.70-2.05-2.17-1.94-1.64-1.35-0.88-0.91
Shares Outstanding 39.37M39.38M39.38M39.38M39.37M44.74M68.21M68.25M68.32M71.20M81.60M87.77M94.37M91.23M101.94M102.37M105.82M107.62M147.62M150.64M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 39.37M39.38M39.38M39.38M39.37M44.74M68.21M68.25M68.32M71.20M81.60M87.77M94.37M91.23M101.94M102.37M105.82M107.62M147.62M150.64M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 39.37M39.38M39.38M39.38M39.37M44.74M68.21M68.32M68.36M81.12M81.81M92.35M94.90M101.22M102.10M105.78M105.80M107.62M150.51M151.02M
EBITDA -55.49M-50.88M-89.77M-197.11M-67.64M-213.41M-77.78M-94.01M-110.55M-153.71M-183.24M-333.77M-178.17M-189.93M-221.56M-211.70M-169.38M-142.73M-130.43M-124.90M
Tax Rate 2.04%-4.97%-8.08%-3.10%-1.80%6.57%-1.35%-2.47%3.11%0.83%-0.32%-0.06%0.04%-0.03%-0.28%-0.13%-0.13%-0.24%-0.21%-0.29%